Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer | Journal of Urology

” Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.” The Journal of Urology, 203(1), pp. 32–33 © 2020 by American Urological Association Education and Research, Inc.

Read the full article here

Related Articles